BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10147358)

  • 1. Prestorage leukocyte reduction of cellular blood components.
    Dzik S
    Transfus Sci; 1994 Jun; 15(2):131-9. PubMed ID: 10147358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implementation of rapid cooling and overnight hold of whole blood at ambient temperature before processing into components in Israel.
    Shinar E; Etlin S; Frenkel O; Yahalom V
    Transfusion; 2011 Jan; 51 Suppl 1():58S-64S. PubMed ID: 21223297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
    Heddle NM; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Blajchman MA; Kelton JG
    Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoreduction of the blood supply in Rhode Island.
    Sweeney JD
    Med Health R I; 1998 Dec; 81(12):386-91. PubMed ID: 9884537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of leukocyte depletion on the storage quality of whole blood].
    Neumeister B; Grauer M; Koch M; Hörnlein R; Dinkelmann S; Bernhard R; Haap M; Northoff H
    Anaesthesist; 1997 Nov; 46(11):979-82. PubMed ID: 9490587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitating blood component preparation: the impact of overnight room temperature storage.
    McLaughlin LS; Moroff G; Benjamin RJ
    Transfusion; 2010 Feb; 50(2):278-80. PubMed ID: 20088837
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukocyte depletion of cellular blood components.
    Lane TA
    Curr Opin Hematol; 1994 Nov; 1(6):443-51. PubMed ID: 9371321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens on leukocyte fragments and plasma proteins: prestorage leukoreduction by filtration.
    Dzik S; Szuflad P; Eaves S
    Vox Sang; 1994; 66(2):104-11. PubMed ID: 8184591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of PMN elastase, TGF-beta1 and neopterin during blood storage; unfiltered versus filtered blood.
    Tylman M; Bengtson JP; Hyllner M; Bengtsson A
    Transfus Apher Sci; 2006 Oct; 35(2):97-102. PubMed ID: 17035091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.
    Cleemput I; Leys M; Ramaekers D; Bonneux L
    Int J Technol Assess Health Care; 2006; 22(4):403-7. PubMed ID: 16984672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of leucocyte-reduced blood components: overestimation of WBC content due to nucleated red blood cells.
    Fischer JC; Moog R; Giers G
    Vox Sang; 2012 Jan; 102(1):79-81. PubMed ID: 21564108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro quality of washed, prestorage leucocyte-depleted red blood cell concentrates.
    Weisbach V; Riego W; Strasser E; Zingsem J; Ringwald J; Zimmermann R; Eckstein R
    Vox Sang; 2004 Jul; 87(1):19-26. PubMed ID: 15260818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2007 Apr; 47(4):687-96. PubMed ID: 17381628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRALI risk reduction: donor and component management strategies.
    Eder AF; Benjamin RJ
    J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current methods in blood preservation: recovery of blood components using a multi-bag system].
    Bergmann H; Blauhut B; Gassner W; Haider M
    Wien Med Wochenschr; 1991; 141(21):485-92. PubMed ID: 1781176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.